Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Monash IVF faces sharp share decline after second embryo mix-up

Monash IVF Group shares have dropped 25% following a second embryo mix-up this year, intensifying concerns over reputational damage and regulatory scrutiny. Despite these setbacks, the company remains a major player in the fertility sector, with strong fundamentals and ongoing expansion in Southeast Asia. Some investors see the current low share price as a potential value opportunity if the company can restore trust and stabilize sentiment. » More on themarketonline.com.au

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Monash IVF Group has already paid €0.0153 in dividends. The last payout was in October.

Financials

In the last quarter, Monash IVF Group had revenue of €79.7m and net profit of €160.49k

(EUR)	June 2026	YoY
Revenue	79.7m	-
Gross profit	17.31m	-
Net profit	160.49k	-
EBITDA	9.97m	-

Fundamentals

Metric	Value
Market capitalization	€175.42m
Number of shares	389.63m
52-week high/low	€0.56 - €0.36
Dividend yield	3.39%
Dividends TTM	€0.0153
Beta	0.34
P/E ratio	37.70
PEG ratio	-0.54
P/B ratio	1.13
P/S ratio	1.04

Company profile

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility research and treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Richmond, Australia.